0001062993-23-023059.txt : 20231221
0001062993-23-023059.hdr.sgml : 20231221
20231221194233
ACCESSION NUMBER: 0001062993-23-023059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACAN WILLIAM ANDREW
CENTRAL INDEX KEY: 0001758584
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38546
FILM NUMBER: 231506851
MAIL ADDRESS:
STREET 1: 24275 KATY FREEWAY, SUITE 600
CITY: KATY
STATE: TX
ZIP: 77494
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neuronetics, Inc.
CENTRAL INDEX KEY: 0001227636
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 877-600-7555
MAIL ADDRESS:
STREET 1: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: NEURONETICS INC
DATE OF NAME CHANGE: 20030416
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-19
0001227636
Neuronetics, Inc.
STIM
0001758584
MACAN WILLIAM ANDREW
C/O NEURONETICS, INC
3222 PHOENIXVILLE PIKE
MALVERN
PA
19355
0
1
0
0
EVP, GC, CCO and CS
1
Common Stock
2023-12-19
4
S
0
11664
2.24
D
372069
D
Common Stock
2023-12-20
4
S
0
11664
2.70
D
360405
D
Common Stock
2023-12-21
4
S
0
11663
2.52
D
348742
D
The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.13 to $2.50. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.42 to $2.90. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.46 to $2.61. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ W. Andrew Macan
2023-12-21